Pacific Biosciences (PACB)
NASDAQ:PACB
Holding PACB?
Track your performance easily

Pacific Biosciences (PACB) Ownership - Who Owns Pacific Biosciences?

2,413 Followers

Pacific Biosciences (PACB) Ownership Overview

2.47%16.63%22.24%23.39%35.27%
22.24% Other Institutional Investors
23.39% ETFs
35.27% Public Companies and Individual Investors
The ownership structure of Pacific Biosciences (PACB) stock is a mix of institutional, retail, and individual investors. Approximately 62.26% of the company’s stock is owned by Institutional Investors, 2.47% is owned by Insiders, and 35.27% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 17, 2024
Christian Henry
President & Ceo
xxxxxxxxxxxxx
$172098
Aug 20, 2024
xxxxxxxxxxxxx
$63098
May 22, 2024
xxxxxxxxxxxxx
$10708
Mar 06, 2024
Christian Henry
President & Ceo
xxxxxxxxxxxxx
$69042

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
33,406,401Institution12.26%82,179,746
31,722,870Institution11.64%78,038,260
18,568,805Institution6.81%45,679,260
15,121,090Institution5.55%37,197,881
13,117,613Institution4.81%32,269,328
3,390,000Institution1.24%8,339,400
3,209,276Institution1.18%7,894,819
3,082,367Institution1.13%7,582,623
2,703,774Institution0.99%6,651,284
2,608,160Institution0.96%6,416,074

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
18,568,805Institution6.81%45,679,260
3,390,000Institution1.24%8,339,400
3,209,276Institution1.18%7,894,819
3,082,367Institution1.13%7,582,623
2,703,774Institution0.99%6,651,284
2,608,160Institution0.96%6,416,074
1,569,434Institution0.58%3,860,808
1,306,523Institution0.48%3,214,047
1,161,008Institution0.43%2,856,080
1,112,319Institution0.41%2,736,305

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
19,864,917Institution7.29%48,867,696
12,586,390Institution4.62%30,962,519
7,493,508Institution2.75%18,434,030
8,930,679Institution3.28%15,182,154
3,926,564Institution1.44%6,675,159
2,612,806Institution0.96%6,427,503
1,826,419Institution0.67%4,492,991
1,209,421Institution0.44%2,781,668
1,254,981Institution0.46%2,133,468
801,923Institution0.29%1,363,269

FAQ

Who Owns Pacific Biosciences (PACB)?
According to the latest TipRanks data, approximately 22.24% of the company's stock is held by institutional investors, 2.47% is held by insiders, and 35.27% is held by retail investors.
    What percentage of Pacific Biosciences (PACB) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 22.24% of Pacific Biosciences (PACB) stock is held by institutional investors.
      What percentage of Pacific Biosciences (PACB) stock is held by retail investors?
      According to the latest TipRanks data, approximately 35.27% of Pacific Biosciences (PACB) stock is held by retail investors.
        Who owns the most shares of Pacific Biosciences (PACB)?
        Cathie Wood owns the most shares of Pacific Biosciences (PACB).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis